BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24203924)

  • 1. Identifying CLL antigens for future combinational therapy.
    Ramsay AG
    Blood; 2013 Nov; 122(19):3241-2. PubMed ID: 24203924
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.
    Dubovsky JA; Chappell DL; Harrington BK; Agrawal K; Andritsos LA; Flynn JM; Jones JA; Paulaitis ME; Bolon B; Johnson AJ; Byrd JC; Muthusamy N
    Blood; 2013 Nov; 122(19):3308-16. PubMed ID: 24009233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
    Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
    HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia.
    Perbellini O; Cioffi F; Malpeli G; Zanolin E; Lovato O; Scarpa A; Pizzolo G; Scupoli MT
    Leuk Lymphoma; 2015 Jun; 56(6):1897-900. PubMed ID: 25347424
    [No Abstract]   [Full Text] [Related]  

  • 5. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
    Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
    Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
    Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis.
    Bojarska-Junak A; Hus I; Chocholska S; Tomczak W; Woś J; Czubak P; Putowski L; Roliński J
    Leuk Res; 2014 Apr; 38(4):435-42. PubMed ID: 24418751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
    Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
    Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression pattern of SLAM family receptors on pathological B cells of patients with chronic lymphocytic leukemia.
    Coma M; Tothova E; Guman T; Hajikova M; Giertlova M; Sarissky M
    Leuk Lymphoma; 2017 Jul; 58(7):1726-1729. PubMed ID: 27869524
    [No Abstract]   [Full Text] [Related]  

  • 12. Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation.
    Payelle-Brogard B; Magnac C; Oppezzo P; Dumas G; Dighiero G; Vuillier F
    Leukemia; 2003 Jun; 17(6):1196-9. PubMed ID: 12764393
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of CD23 isoforms on B-chronic lymphocytic leukemia.
    Goller ME; Kneitz C; Mehringer C; Müller K; Jelley-Gibbs DM; Gosselin EJ; Wilhelm M; Tony HP
    Leuk Res; 2002 Sep; 26(9):795-802. PubMed ID: 12127553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases.
    Parisi-Duchêne E; Mazurier I; Moskovtchenko P
    Acta Haematol; 2006; 115(1-2):74-7. PubMed ID: 16424654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Zucchetto A; Caldana C; Benedetti D; Tissino E; Rossi FM; Hutterer E; Pozzo F; Bomben R; Dal Bo M; D'Arena G; Zaja F; Pozzato G; Di Raimondo F; Hartmann TN; Rossi D; Gaidano G; Del Poeta G; Gattei V
    Blood; 2013 Nov; 122(19):3317-21. PubMed ID: 24068493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia.
    Saint-Georges S; Quettier M; Bouyaba M; Le Coquil S; Laurienté V; Guittat L; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N; Le Roy C; Ledoux D
    Oncotarget; 2016 Jul; 7(27):41031-41046. PubMed ID: 27127886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells.
    Cattaneo F; Patrussi L; Capitani N; Frezzato F; D'Elios MM; Trentin L; Semenzato G; Baldari CT
    Oncotarget; 2016 Aug; 7(35):57086-57098. PubMed ID: 27494881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
    Ganghammer S; Gutjahr J; Hutterer E; Krenn PW; Pucher S; Zelle-Rieser C; Jöhrer K; Wijtmans M; Leurs R; Smit MJ; Gattei V; Greil R; Hartmann TN
    Haematologica; 2016 Mar; 101(3):e99-102. PubMed ID: 26589908
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.